Éva Karászi

485 total citations
17 papers, 389 citations indexed

About

Éva Karászi is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Éva Karászi has authored 17 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Éva Karászi's work include Acute Myeloid Leukemia Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). Éva Karászi is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). Éva Karászi collaborates with scholars based in Hungary, United Kingdom and Spain. Éva Karászi's co-authors include László Homolya, Balázs Sarkadi, Tamás I. Orbán, Ágota Apáti, Anita Schamberger, Katalin Német, György Várady, Andrea H. Németh, Katalin Jakab and Nóra Varga and has published in prestigious journals such as Biochemical Journal, Frontiers in Immunology and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Éva Karászi

15 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éva Karászi Hungary 8 205 142 78 70 53 17 389
Tomoo Osumi Japan 11 110 0.5× 104 0.7× 90 1.2× 40 0.6× 31 0.6× 54 374
Arianna Brevi Italy 9 215 1.0× 142 1.0× 87 1.1× 143 2.0× 18 0.3× 11 405
Juying Wei China 12 105 0.5× 212 1.5× 56 0.7× 81 1.2× 36 0.7× 44 380
Seyed Esmaeil Ahmadi Iran 10 206 1.0× 74 0.5× 76 1.0× 35 0.5× 36 0.7× 16 364
Naoko Sakaguchi Japan 12 251 1.2× 83 0.6× 48 0.6× 166 2.4× 45 0.8× 19 490
Saskia Gueller United States 14 199 1.0× 80 0.6× 148 1.9× 48 0.7× 73 1.4× 19 468
Filomena Napolitano Italy 12 118 0.6× 63 0.4× 41 0.5× 90 1.3× 25 0.5× 27 319
Itsaso Mauleón Spain 14 337 1.6× 168 1.2× 49 0.6× 97 1.4× 229 4.3× 19 557
Elke Malenke Germany 9 126 0.6× 82 0.6× 30 0.4× 92 1.3× 25 0.5× 13 303
AG Dalgleish United Kingdom 5 156 0.8× 121 0.9× 60 0.8× 129 1.8× 33 0.6× 6 383

Countries citing papers authored by Éva Karászi

Since Specialization
Citations

This map shows the geographic impact of Éva Karászi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éva Karászi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éva Karászi more than expected).

Fields of papers citing papers by Éva Karászi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éva Karászi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éva Karászi. The network helps show where Éva Karászi may publish in the future.

Co-authorship network of co-authors of Éva Karászi

This figure shows the co-authorship network connecting the top 25 collaborators of Éva Karászi. A scholar is included among the top collaborators of Éva Karászi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éva Karászi. Éva Karászi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Karászi, Éva, et al.. (2025). A hazai A-csoportú Streptococcus (GAS-) járvány jellemzői a gyermek-alapellátásban 2023-ban. Orvosi Hetilap. 166(19). 719–727.
2.
Karászi, Éva, Zsófia Mészner, Botond Lakatos, et al.. (2025). Az RSV-fertőzések jellemzői és prevenciós lehetőségei. Orvosi Hetilap. 166(35). 1362–1373. 1 indexed citations
3.
Szabó, Liliána, Z Szabó, Éva Karászi, et al.. (2023). T cell immune response predicts survival in severely ill COVID-19 patients requiring venovenous extracorporeal membrane oxygenation support. Frontiers in Immunology. 14. 1179620–1179620. 2 indexed citations
4.
Karászi, Éva, János Szlávik, Vera Goda, et al.. (2023). Infekciók kockázatának csökkentése veleszületett és szerzett komplementdefektusokban.. Orvosi Hetilap. 164(25). 971–980. 1 indexed citations
5.
Karászi, Éva, et al.. (2021). Az alapellátásban kezelt COVID–19-fertőzött gyermekek tünettani és epidemiológiai jellemzői. Orvosi Hetilap. 162(44). 1751–1760. 3 indexed citations
6.
Karászi, Éva, Gergely Kriván, Krisztián Kállay, et al.. (2019). Identification of the best‐suited donor for generating virus‐specific T cells. Vox Sanguinis. 115(1). 18–26. 3 indexed citations
7.
Bátai, Árpád, Péter Reményi, Marienn Réti, et al.. (2017). Allogén vérképzőőssejt-átültetés Magyarországon. Orvosi Hetilap. 158(8). 291–297.
9.
Mátrai, Zoltán, Hajnalka Andrikovics, Anikó Szilvási, et al.. (2016). Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia. Pathology & Oncology Research. 23(1). 165–171. 5 indexed citations
10.
Koszarska, Magdalena, András Bors, Árpád Bátai, et al.. (2012). Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia. Leukemia & lymphoma. 54(5). 1028–1035. 27 indexed citations
11.
Orbán, Tamás I., Ágota Apáti, Andrea H. Németh, et al.. (2009). Applying a “Double-Feature” Promoter to Identify Cardiomyocytes Differentiated from Human Embryonic Stem Cells Following Transposon-Based Gene Delivery. Stem Cells. 27(5). 1077–1087. 50 indexed citations
12.
Apáti, Ágota, Tamás I. Orbán, Nóra Varga, et al.. (2008). High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1778(12). 2700–2709. 71 indexed citations
13.
Kappelmayer, János, et al.. (2002). "Pros and Cons" on How to Measure Multidrug Resistance in Leukemias. Leukemia & lymphoma. 43(4). 711–717. 6 indexed citations
14.
Kappelmayer, János, et al.. (2001). Identification of P‐selectin glycoprotein ligand‐1 as a useful marker in acute myeloid leukaemias. British Journal of Haematology. 115(4). 903–909. 25 indexed citations
15.
Karászi, Éva, Katalin Jakab, László Homolya, et al.. (2001). Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia. British Journal of Haematology. 112(2). 308–314. 66 indexed citations
16.
Gratama, Jan W., et al.. (2000). Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Journal of Immunological Methods. 242(1-2). 53–65. 43 indexed citations
17.
Szondy, Zsuzsa, Uwe Reichert, Jean‐Michel Bernardon, et al.. (1998). Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor α. Biochemical Journal. 331(3). 767–774. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026